Researchers at the Paul Scherrer Institute PSI and the University of Basel have developed a rapid test for COVID-19. Its novel functional principle promises reliable and quantifiable results concerning a patient’s COVID-19 disease and its course—as well as evidence concerning other diseases and COVID variants that may be present. Before it can go into widespread use, however, it still must undergo further testing and optimisation. The researchers report on their development in the journal ACS Applied Nanomaterials.
Now a new test developed at PSI—which, unlike antigen tests, does not directly detect components of the virus, but rather the antibodies the immune system produces in response to the infection –promises to bring substantially more predictive power to rapid testing. It is just as inexpensive, quick, and easy to use, and it can also be used to simultaneously identify a variety of pathogens, such as those responsible for the flu. “Thus, it also provides more data than previous rapid antibody tests that are used to determine whether someone has already had a coronavirus infection,” says Yasin Ekinci, head of the Laboratory for X-ray Nanoscience and Technologies at PSI, who was responsible for the project to develop the new test.
The central building block of the test is a small rectangular plate of ordinary Plexiglas, similar to a microscope slide. It consists of a lower layer which is one millimeter thick, and an upper layer with a thickness of 0.2 millimeters. The researchers patterned a relief in the lower part using electron beam lithography—an extremely precise process for milling solid materials used, for example, in the manufacturing of computer chips. Once the master template was produced in this way, the researchers combined this with so-called nanoimprint lithography, which significantly speeds up the fabrication process and reduces its cost.
Multifunctional microstructure
With the thinner layer of Plexiglas as a cover, the plate now has three parallel channels through which a fluid can flow from one end to the other. Each of these is 300 micrometers (0.3 millimeter) wide and 3.4 micrometer high at the inlet. At the outlet, the channels are five times as wide but only one micrometer high. Along a stretch in between, the channel narrows to just a few micrometers wide, and at one point it is only 0.8 micrometer high—roughly 100 times thinner than human hair.
“This special channel structure serves several purposes at once,” says Thomas Mortelmans, a doctoral candidate at the Swiss Nanoscience Institute of the University of Basel and first author of the study. Mortelmans carried out his research at PSI’s Laboratory for X-ray Nanoscience and Technologies. For one thing, it ensures a strong capillary effect, like the familiar action of the conduit tissues that transport water from the roots to the crowns of trees. No pump is required. The force results from the interfacial tension between the liquid and the solid surface. It virtually sucks the water through the narrow passages. Precisely the same thing happens with the channels in the Plexiglas—except that instead of water, a droplet of blood flows through it.
What is crucial for the test is a passage in which the height of the channel drops from 3.4 micrometers to 0.8. In what the researchers call the capture region, particles previously added to the blood get stuck at predefined locations—depending on which pathogens are present in the blood. For the test, Mortelmans explains, a subject would go to a doctor or a test center. There, a little drop of blood is taken with a prick of the finger, as in a blood sugar test. A liquid in which special artificial nanoparticles are suspended is mixed into the blood. Their surface has the same structure as the notorious spike proteins of the SARS-CoV-2 virus, which human antibodies dock to when fighting the disease. In addition, small fluorescent particles are added that attach themselves to SARS-CoV-2 antibodies in humans.
This means that if there are antibodies against SarsCoV-2 in the blood being tested, the fluorescent particles first attach themselves to them; together they then bind to the virus-like structures of the significantly larger nanoparticles and get stuck, along with them, in the predefined places corresponding to the diameter of the nanoparticles. “That is where the channel is exactly 2.8 micrometers high,” says Mortelmans. Here the nanoparticles accumulate, with the human antibodies and their glowing appendages docked to them. If the plate is placed under a fluorescence microscope, the light signal is visible. The more antibodies the patient has formed, the brighter it is; the clearer the signal, the stronger the immune reaction. This is how COVID-19 can be clearly diagnosed. “In addition, you can use the signal strength to see whether the immune system is reacting well and a mild course can be expected—or whether it might be overreacting, meaning there is a risk of complications,” explains Mortelmans.
One rapid test with many possibilities
There is no risk of the channel becoming blocked by other particles in the blood. The viruses themselves are only around 0.12 micrometer in size and flow through without resistance. Only the red blood cells next to the nanoparticles are larger than the narrowest part of the channel. “At the beginning of our development project, they actually caused problems,” says Mortelmans. “But we have optimized the channel so that they now slip through.” The researchers took advantage of the fact that the cells are flexible and compressible: “The capillary force is now so great that it squeezes the blood cells through every narrowing of the channel.”
The test opens up even more possibilities beyond diagnosing COVID-19. In addition, nanoparticles of different sizes and with different surface structures could be mixed into the blood to enable simultaneous testing for other diseases. In the study, Mortelmans did this using particles whose surface corresponds to influenza A viruses. In the experiments, two spots in the capture region lit up: one for COVID-19 and one for the flu.
In addition, it is possible to identify different antibodies that the immune system produces in different stages of the disease. For example, one could use green fluorescent particles that only attach to antibodies that appear in the early phase of the infection, and red fluorescent particles for antibodies that are produced by the immune system at later stages. “The test can be extended in many ways,” says Mortelmans. “We could, for example, test ten different diseases at once without any problems and use four colors as well.” Of course, the number of channels could also be increased to test even more variants. In principle, the second and third channels are only there to confirm the result of the first. However, they could also be used to carry out different tests. “In principle, we have a system here similar to Lego, in which you can combine different components,” says project manager Yasin Ekinci.
The researchers began their work on the new test shortly after the start of the coronavirus pandemic. “We were working on a diagnostic test for Parkinson’s at the time,” says Ekinci. “When the pandemic took hold, we asked ourselves how we, as a research institute, could contribute to overcoming it.” However, the development took longer because the test is so novel, because little was known about the virus at the beginning, and because patient samples were also difficult to obtain.
For the study, the device was tested with 29 blood samples—19 of which came from infected people and 10 from non-infected people. With the exception of one false-negative case, the test was always correct. This too was identified during the follow-up test. “Of course we need to do a lot more testing to make a solid statement about reliability, and there’s still a lot of room for improvement. But it is very promising,” says Ekinci.
In addition, the test should become even easier to carry out. “We’re working on making it just as easy to do with saliva instead of blood,” Mortelmans reports. “We also want to be able to use a mobile phone camera instead of a microscope to read the signals. Modern devices are now capable of doing this.” Such a test currently takes between 10 and 30 minutes. But it also be possible to do it in two minutes; it is currently being optimized with that aim. “Our vision is a technology,” says Ekinci, “with which we can simultaneously diagnose several diseases and variants of COVID and flu reliably, quickly, and inexpensively via mobile phone. Our novel concept is capable of making this a reality.”

News
Emission of Fe- and Ti-Containing Nanoparticles from Coal-Fired Power Plants
In an article published in the journal Science of the Total Environment, researchers have highlighted the significance and potential risks associated with the release of nanoparticles from coal-fired power plants. Applying the single-particle inductively coupled plasma mass [...]
Covalent Organic Framework Nanofluidic Hybrid Membrane for Osmotic Energy Generation
A paper recently published in the journal ACS Applied Energy Materials demonstrated the feasibility of using a covalent organic framework (COF)-based nanofluidic hybrid membranes (NHMs) to attain enhanced interfacial ion transport for the generation of osmotic [...]
Degradable Nanocomposite Removes Antibiotics from Contaminated Water
The excess fluoroquinolones (FQs) discharged into the aquatic environment due to human activities must be removed cost-effectively. In an article published in the Journal of Cleaner Production, the authors fabricated an environment-friendly dealkaline lignin-grafted Fe3O4 nanoparticles [...]
Light-controlled reactions at the nanoscale
Controlling strong electromagnetic fields on nanoparticles is the key to triggering targeted molecular reactions on their surfaces. Such control over strong fields is achieved via laser light. Although laser-induced formation and breaking of molecular [...]
Bright Future for Nanophotonic Chips with Topological Rainbow Device
A paper recently published in the journal Nature Communications demonstrated an effective method to realize on-chip nanophotonic topological rainbow devices using the concept of synthetic dimensions. Importance of Synthetic Dimensions for the Construction of Topological Nanophotonics [...]
Green Approach to Silver Nanoparticle Fabrication with Citrus Fruits
In a study available in the journal Materials Today: Proceedings, silver nanoparticles (Ag NPs) were fabricated using a green method using Citrus X sinensis. Methylthioninium Chloride (MB) Dyes Threatening the Environment Dye and sewage drainage into [...]
Coronavirus ‘ghosts’ found lingering in the gut
Scientists are studying whether long COVID could be linked to viral fragments found in the body months after initial infection. In the chaos of the first months of the coronavirus pandemic, oncologist and geneticist [...]
Experts perplexed over number of people getting long COVID
Public health experts are divided over how many people are getting long COVID-19, a potentially debilitating condition that comes after a patient has recovered from the coronavirus. Ill effects from the condition can include [...]
Four strange COVID symptoms you might not have heard about
Well over two years into the pandemic, hundreds of thousands of COVID cases continue to be recorded around the world every day. With the rise of new variants, the symptoms of COVID have also evolved. Initially, [...]
A new method for exploring the nano-world
Nanoparticles are everywhere. They are in our body as protein aggregates, lipid vesicles, or viruses. They are in our drinking water in the form of impurities. They are in the air we breath as [...]
Breast Cancer Drug Resistance Tackled By Polymer Nanoparticles
Drug resistance is a common phenomenon, with drugs becoming less and less effective as their usage increases. To address this issue, a novel technique employing conjugated polymer-based nanoparticles is presented in the study published [...]
New imaging method makes microrobots visible in the body
Microrobots have the potential to revolutionize medicine. Researchers at the Max Planck ETH Centre for Learning Systems have now developed an imaging technique that for the first time recognises cell-sized microrobots individually and at [...]
Multifunctional Nanocrystals Enhance Cancer Cell Killing Therapies
Scientists have recently developed multifunctional hexagonal NaxWO3 nanocrystals that can serve as microwave sensitizers to kill cancer cells as well as improve the overall chemodynamic therapy (CDT). This study is available as a pre-proof in Chemical Engineering Journal. [...]
Biotech, nanomedicine, and AI combine for health breakthrough predicted by Apple genius Steve Jobs
Apple’s visionary founder, the late Steve Jobs once said, “the biggest innovations of the 21st century will be at the intersection of biology and technology”. And that prediction is coming true in the drug [...]
Making chemical separation more eco-friendly with nanotechnology
Chemical separation processes are essential in the manufacturing of many products from gasoline to whiskey. Such processes are energetically costly, accounting for approximately 10–15 percent of global energy consumption. In particular, the use of [...]
Dual Function SARS-CoV-2 Sensor for Point of Contact Testing
Scientists have recently developed electrochemical immunosensors based on graphene oxide−gold (GO−Au) nanocomposites. These immunosensors are highly sensitive with dual function, i.e., they can detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen and antibody. [...]